Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation
HemaSphere · 2024-12 · 8 (12)
DOI: 10.1002/hem3.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift HemaSphere, online erschienen am 17.12.2024. Verfasst von Konradin F Müskens und 9 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Stichting Kinderen Kankervrij, European Hematology Association.
Abstract (Originalsprache)
Despite advances in allogeneic hematopoietic cell transplantation (HCT), poor graft function (PGF) remains an important complication with substantial morbidity and mortality. The investigation of preventive and therapeutic PGF treatments is hindered by inconsistencies in reported incidence and outcomes across studies, which may be explained by heterogeneity in PGF definition. To assess the impact of definition heterogeneity, we conducted a multicenter study, analyzing over 35.000 longitudinal blood counts from 427 pediatric and 405 adult HCT recipients. We compared the incidence, risk factors, and outcome of PGF, based on the three most common definitions. We identified 97 pediatric and 75 adult HCT recipients fulfilling at least one PGF definition. The 2‐year cumulative incidence of PGF varied significantly depending on the definition used, ranging from 6.8% to 20% in children and 4.9% to 18% in adults. Two‐year mortality for PGF patients ranged from 33% to 40% in children and 46% to 65% in adults. Notably, PGF patients identified solely by lenient definitions had similar mortality to HCT recipients with good graft function. Risk factors for PGF also varied by definition in both cohorts, and included older recipient age and cord blood transplantation. In conclusion, our study demonstrates that differences in PGF definition significantly impact the reported incidence, risk factors, and outcome. This underscores the need to harmonize PGF definitions across scientific studies, clinical practice, and transplant registries. Future studies, using standardized, quantitative thresholds for PGF, are required to determine optimal treatment strategies for both mild and severe forms of PGF.
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
- Central Diagnostic Laboratory, University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
- Department of Hematology, University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
- Laboratory of Translational Immunology University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
- Wilhelmina Children's Hospital, University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
ORCID-Profile: Mirjam E Belderbos
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Stichting Kinderen Kankervrij
- European Hematology Association
Zitieren
APA
Müskens, K. F., Collot-d'Escury, W. N. R., Dandis, R., Haitjema, S., Kuball, J., de Witte, M. A., Bierings, M., Lindemans, C. A., Nierkens, S., & Belderbos, M. E. (2024). Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation. HemaSphere, 8(12). https://doi.org/10.1002/hem3.70059
Vancouver
Müskens KF, Collot-d'Escury WNR, Dandis R, Haitjema S, Kuball J, de Witte MA, et al. Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation. HemaSphere. 2024;8(12). doi:10.1002/hem3.70059
BibTeX
@article{Mskens2024,
author = {Müskens, Konradin F and Collot-d'Escury, Winny N R and Dandis, Rana and Haitjema, Saskia and Kuball, Jürgen and de Witte, Moniek A and Bierings, Marc and Lindemans, Caroline A and Nierkens, Stefan and Belderbos, Mirjam E},
title = {Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation},
journal = {HemaSphere},
year = {2024},
volume = {8},
number = {12},
doi = {10.1002/hem3.70059}
}
EUVIMED